Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 08:57:22 UTC |
---|
Update Date | 2021-09-26 23:03:40 UTC |
---|
HMDB ID | HMDB0251589 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Doravirine |
---|
Description | Doravirine belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. A) or moderate (Child-Pugh Class. Doravirine is a moderately basic compound (based on its pKa). No dosage adjustment of doravirine is required in patients with mild, moderate, or severe renal impairment. C), or <18 years of age is unknown . Once administered and absorbed into the plasma circulation, unchanged doravirine is the major circulating component, followed by its M9 metabolite - a product of cytochrome P450 3A4/5 mediated oxidative metabolism, resulting in the addition of oxygen to doravirine's triazolone ring - as the most abundant doravirine metabolite present . Doravirine is subsequently available by itself or as a combination product of doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg) . The pharmacokinetics of doravirine in patients with end-stage renal disease or undergoing dialysis, severe hepatic impairment (Child-Pugh. This compound has been identified in human blood as reported by (PMID: 31557052 ). Doravirine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Doravirine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN1C(O)=NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28) |
---|
Synonyms | Value | Source |
---|
MK-1439DORAVIRINE | ChEMBL |
|
---|
Chemical Formula | C17H11ClF3N5O3 |
---|
Average Molecular Weight | 425.749 |
---|
Monoisotopic Molecular Weight | 425.050251565 |
---|
IUPAC Name | 3-chloro-5-({1-[(5-hydroxy-4-methyl-4H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile |
---|
Traditional Name | 3-chloro-5-({1-[(5-hydroxy-4-methyl-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)pyridin-3-yl}oxy)benzonitrile |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1C(O)=NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F |
---|
InChI Identifier | InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28) |
---|
InChI Key | ZIAOVIPSKUPPQW-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Ethers |
---|
Direct Parent | Diarylethers |
---|
Alternative Parents | |
---|
Substituents | - Diaryl ether
- Benzonitrile
- Phenoxy compound
- Phenol ether
- Chlorobenzene
- Dihydropyridine
- Halobenzene
- Pyridinone
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Hydropyridine
- Pyridine
- Benzenoid
- Azole
- 1,2,4-triazole
- Heteroaromatic compound
- Lactam
- Organoheterocyclic compound
- Azacycle
- Nitrile
- Carbonitrile
- Hydrocarbon derivative
- Organic oxide
- Cyanide
- Organic nitrogen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Alkyl fluoride
- Organofluoride
- Alkyl halide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Doravirine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0wmi-1539200000-bc5dd78c5dc9b16615e9 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Doravirine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Doravirine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Doravirine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 10V, Positive-QTOF | splash10-004i-1102900000-85159263a4e1f67db4fd | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 20V, Positive-QTOF | splash10-02ta-0219100000-d6ddc6a4128222a041d1 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 40V, Positive-QTOF | splash10-053i-8928000000-39d7c30b07d1de9e85d9 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 10V, Negative-QTOF | splash10-014i-2009000000-f1affba5de17dc10816d | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 20V, Negative-QTOF | splash10-014i-1109100000-d953f236c324da9b5329 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 40V, Negative-QTOF | splash10-0zfu-4912000000-7eac1fbcbbae47e7fb50 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 10V, Positive-QTOF | splash10-004i-0000900000-c2c10af104f690d1e43c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 20V, Positive-QTOF | splash10-004r-0109400000-f42cb9021f31cd5b24ab | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 40V, Positive-QTOF | splash10-0f9i-3819000000-209cda74b17fdb5cce5f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 10V, Negative-QTOF | splash10-00di-0401900000-17fb69f803a4a3e2aa13 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 20V, Negative-QTOF | splash10-0udi-5809000000-c18aeb067425b7980067 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Doravirine 40V, Negative-QTOF | splash10-001i-9001000000-7e76979acba163304f23 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|